Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking [NA]

View source ↗

Summary

A clinical trial registration for intermittent nonprescription glucose sensors to track health in non–insulin-dependent Type 2 diabetes; the study status is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 2 Diabetes, Non Insulin Dependent Diabetes | NA | Status: NOT_YET_RECRUITING